Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-(1H-indol-7-yl)-4-methoxybenzenesulfonamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

247186-85-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 247186-85-2 Structure
  • Basic information

    1. Product Name: N-(1H-indol-7-yl)-4-methoxybenzenesulfonamide
    2. Synonyms: N-(1H-indol-7-yl)-4-methoxybenzenesulfonamide
    3. CAS NO:247186-85-2
    4. Molecular Formula:
    5. Molecular Weight: 302.354
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 247186-85-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: N-(1H-indol-7-yl)-4-methoxybenzenesulfonamide(CAS DataBase Reference)
    10. NIST Chemistry Reference: N-(1H-indol-7-yl)-4-methoxybenzenesulfonamide(247186-85-2)
    11. EPA Substance Registry System: N-(1H-indol-7-yl)-4-methoxybenzenesulfonamide(247186-85-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 247186-85-2(Hazardous Substances Data)

247186-85-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 247186-85-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,7,1,8 and 6 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 247186-85:
(8*2)+(7*4)+(6*7)+(5*1)+(4*8)+(3*6)+(2*8)+(1*5)=162
162 % 10 = 2
So 247186-85-2 is a valid CAS Registry Number.

247186-85-2Relevant articles and documents

Cu(II)-Mediated Cross-Dehydrogenative Coupling of Indolines with Sulfonamides, Carboxamides, and Amines

Kumar, Mohit,Raziullah,Khan, Afsar Ali,Ahmad, Ashfaq,Dutta, Himangsu Sekhar,Kant, Ruchir,Koley, Dipankar

, (2019)

A facile and efficient Cu-mediated protocol for the cross-dehydrogenative coupling of indoline with sulfonamides, carboxamides, and anilines is reported. The reaction takes place through Cu-mediated C7-H activation via a 6-membered metallacycle to afford the amide and amine derivatives in good yields with a wide range of functional group tolerance. The importance of the protocol has been demonstrated by synthesizing the antiproliferative agent, ER-67836.

Cu(II)-Mediated Cross-Dehydrogenative Coupling of Indolines with Sulfonamides, Carboxamides, and Amines

Kumar, Mohit,Raziullah,Khan, Afsar Ali,Ahmad, Ashfaq,Dutta, Himangsu Sekhar,Kant, Ruchir,Koley, Dipankar

, p. 13624 - 13635 (2019/11/14)

A facile and efficient Cu-mediated protocol for the cross-dehydrogenative coupling of indoline with sulfonamides, carboxamides, and anilines is reported. The reaction takes place through Cu-mediated C7-H activation via a 6-membered metallacycle to afford the amide and amine derivatives in good yields with a wide range of functional group tolerance. The importance of the protocol has been demonstrated by synthesizing the antiproliferative agent, ER-67836.

A Direct Access to 7-Aminoindoles via Iridium-Catalyzed Mild C-H Amidation of N-Pivaloylindoles with Organic Azides

Kim, Youyoung,Park, Juhyeon,Chang, Sukbok

, p. 1892 - 1895 (2016/05/19)

Ir(III)-catalyzed regioselective direct C-7 amidation of indoles in reaction with organic azides has been developed. While its efficiency was varied by the choice of N-directing groups, N-pivaloylindoles were most effective in undergoing the desired amidation at room temperature over a broad range of substrates. The reaction was scalable, and deprotection of the chelation group was also facile.

Iridium(III)-catalyzed regioselective C7-sulfonamidation of indoles

Song, Zengqiang,Antonchick, Andrey P.

, p. 4804 - 4808 (2016/06/13)

Iridium(iii)-catalyzed direct C7-sulfonamidation of indoles with sulfonyl azides is described. The developed method has good compatibility with diverse functional groups, providing various 7-amino-substituted indoles with good to excellent yields in a sho

Benzenesulfonamide derivatives and pharmaceutical composition thereof

-

, (2011/10/10)

The present invention is related to derivatives of benzenesulfonamide represented by formula (I), and the pharmaceutical composition thereof. In addition, the benzenesulfonamide derivatives disclosed in the present invention can serve as potential cell cycle inhibitors, and thereby these benzenesulfonamide derivatives and the pharmaceutical composition thereof can be antitumor drug candidates, which might aim at cell cycle. Particularly, the benzenesulfonamide derivatives disclosed in the present invention may function as antitumor drugs to treat solid cancers.

LYMPHOCYTIC ACTIVATION INHIBITOR AND REMEDIAL AGENT FOR AUTOIMMUNE DISEASE

-

, (2008/06/13)

A lymphocyte activation inhibitor and a therapeutic agent for an autoimmune disease, each comprising, as an active ingredient, a sulfonamide derivative or sulfonic acid ester derivative represented by the following general formula (I): wherein the ring A represents a monocyclic or bicyclic aromatic ring which may be substituted, the ring B represents a 6-membered unsaturated hydrocarbon ring or a 6-membered unsaturated heterocyclic ring containing one nitrogen atom as a heteroatom, each of which may be substituted, the ring C represents a 5-membered heterocyclic ring containing one or two nitrogen atoms, which may be substituted, W represents a single bond or -CH=CH-, X represents -N(R1)- or an oxygen atom, Y represents a carbon atom or a nitrogen atom, Z represents -N(R2)- or a nitrogen atom, and R1 and R2 may be identical or different and each represents a hydrogen atom or a lower alkyl group, or a pharmacologically acceptable salt thereof, or a hydrate thereof.

A focused compound library of novel N-(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors

Owa, Takashi,Okauchi, Tatsuo,Yoshimatsu, Kentaro,Sugi, Naoko Hata,Ozawa, Yoichi,Nagasu, Takeshi,Koyanagi, Nozomu,Okabe, Tadashi,Kitoh, Kyosuke,Yoshino, Hiroshi

, p. 1223 - 1226 (2007/10/03)

A series of compounds containing an N-(7-indolyl)benzenesulfonamide pharmacophore was synthesized and evaluated as a potential antitumor agent. Cell cycle analysis with P388 murine leukemia cells revealed that there were two different classes of potent cell cycle inhibitors; one disrupted mitosis and the other caused G1 accumulation. Herein described is the SAR summary of the substituent patterns on this pharmacophore template. (C) 2000 Elsevier Science Ltd. All rights reserved.

Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle

Owa, Takashi,Yoshino, Hiroshi,Okauchi, Tatsuo,Yoshimatsu, Kentaro,Ozawa, Yoichi,Sugi, Naoko Hata,Nagasu, Takeshi,Koyanagi, Nozomu,Kitoh, Kyosuke

, p. 3789 - 3799 (2007/10/03)

Described herein is the discovery of a novel series of antitumor sulfonamides targeting G1 phase of the cell cycle. Cell cycle control in G1 phase has attracted considerable attention in recent cancer research, because many of the important proteins invol

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 247186-85-2